Anika Therapeutics Inc
ANIK8.900USD
-0.040-0.45%
收盘 09/19, 16:00（美东）报价延迟15分钟
128.32M总市值
亏损市盈率 TTM
关于 Anika Therapeutics Inc 公司
Anika Therapeutics, Inc. 是一家全球性关节保护公司。该公司在早期干预骨科护理领域创造和提供进步，包括骨关节炎 (OA) 疼痛管理、再生解决方案和运动医学领域。该公司专注于开发、制造和商业化其透明质酸 (HA) 技术平台上的产品。其 OA 疼痛管理产品系列包括 Monovisc 和 Orthovisc，其可注射的 HA、OA 疼痛管理产品旨在缓解骨关节炎引起的疼痛；以及 Cingal，其新型、下一代、单次注射 OA 疼痛管理产品，由其专有的交联 HA 材料与类固醇结合而成。其关节保护和修复产品系列包括利用 HA 的骨科再生解决方案产品组合，包括 Integrity，其用于肩袖和其他肌腱修复的新型透明质酸基支架。
公司简介
公司代码ANIK
公司名称Anika Therapeutics Inc
上市日期May 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
员工数量288
证券类型Ordinary Share
年结日May 16
公司地址32 Wiggins Ave
城市BEDFORD
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编01730-2315
电话17814579000
网址https://anika.com/
公司代码ANIK
上市日期May 16, 1985
CEODr. Cheryl Renee Blanchard, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
Mr. Ian McLeod
Mr. Ian McLeod
Chief Accounting Officer, Vice President, Treasurer
Chief Accounting Officer, Vice President, Treasurer
--
--
Mr. Gary P. Fischetti
Mr. Gary P. Fischetti
Independent Director
Independent Director
--
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+39.24%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+55.16%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+158.45%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+227.02%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
9.07K
--
Mr. Matt Hall
Mr. Matt Hall
Director, Corporate Development and Investor Relations
Director, Corporate Development and Investor Relations
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
OEM Channel
14.91M
56.97%
Commercial Channel
11.26M
43.03%
地区USD
名称
营收
占比
United States
16.36M
62.53%
Europe
5.80M
22.16%
Other
4.01M
15.31%
业务
地区
业务USD
名称
营收
占比
OEM Channel
14.91M
56.97%
Commercial Channel
11.26M
43.03%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
其他
59.69%
持股股东
持股股东
占比
Trigran Investments, Inc.
14.12%
Caligan Partners, LP
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.41%
Dimensional Fund Advisors, L.P.
4.32%
其他
59.69%
股东类型
持股股东
占比
Hedge Fund
37.86%
Investment Advisor/Hedge Fund
26.83%
Investment Advisor
22.71%
Individual Investor
4.88%
Research Firm
1.06%
Pension Fund
0.35%
Bank and Trust
0.13%
Insurance Company
0.03%
其他
6.14%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
302
13.74M
95.32%
-1.50M
2025Q1
310
13.52M
94.22%
-1.59M
2024Q4
308
13.33M
91.05%
-2.02M
2024Q3
309
13.98M
94.53%
-1.95M
2024Q2
313
14.09M
95.06%
-2.05M
2024Q1
312
14.07M
96.09%
-1.66M
2023Q4
314
13.84M
94.50%
-1.88M
2023Q3
309
13.57M
92.73%
-2.13M
2023Q2
310
13.73M
93.04%
-2.32M
2023Q1
326
13.65M
93.27%
-2.92M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Trigran Investments, Inc.
2.04M
14.24%
+20.07K
+0.99%
Mar 31, 2025
Caligan Partners, LP
1.44M
10.01%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
957.43K
6.68%
-49.29K
-4.90%
Mar 31, 2025
The Vanguard Group, Inc.
777.40K
5.42%
+12.13K
+1.59%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
613.97K
4.28%
-43.38K
-6.60%
Mar 31, 2025
Opaleye Management Inc.
395.00K
2.75%
+395.00K
--
Mar 31, 2025
Acadian Asset Management LLC
539.61K
3.76%
+63.90K
+13.43%
Mar 31, 2025
BlackRock Financial Management, Inc.
522.01K
3.64%
+11.71K
+2.30%
Mar 31, 2025
Boothbay Fund Management, LLC
529.50K
3.69%
--
--
Mar 31, 2025
Renaissance Technologies LLC
528.62K
3.69%
+100.00
+0.02%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
